More

    Europe Markets

    Veoza | European Medicines Agency (EMA)

    OverviewVeoza is a medicine used to treat moderate to severe vasomotor symptoms (also referred to as hot flushes or night sweats) associated with...

    Ambrisentan Viatris (previously Ambrisentan Mylan)

    OverviewAmbrisentan Viatris is a medicine that is used alone or combined with other medicines to treat adults with pulmonary arterial hypertension (PAH).PAH is abnormally...

    Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2025

    At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management...

    Opfolda | European Medicines Agency (EMA)

    OverviewOpfolda is a medicine used in the treatment of adults with late-onset Pompe disease (acid alpha-glucosidase deficiency), an inherited disorder in which...

    Lyumjev (previously Liumjev) | European Medicines Agency (EMA)

    OverviewLyumjev is a medicine used to control blood glucose (sugar) levels in adults and children aged 1 year and above with diabetes. It...

    Beyfortus | European Medicines Agency (EMA)

    OverviewBeyfortus is a medicine used to prevent serious lower respiratory tract (lung) disease caused by respiratory syncytial virus (RSV) in newborns and children...

    Karvea | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Karvea. It explains how the Committee for Medicinal Products for Human...

    Fasenra | European Medicines Agency (EMA)

    OverviewFasenra is an asthma medicine used to treat adults with a particular type of asthma called eosinophilic asthma. It is used as an...

    Dimethyl fumarate Neuraxpharm | European Medicines Agency (EMA)

    OverviewDimethyl fumarate Neuraxpharm is a medicine used to treat multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves...

    Docetaxel Accord | European Medicines Agency (EMA)

    OverviewDocetaxel Accord is a cancer medicine used to treat the following types of cancer:breast cancer. Docetaxel Accord can be used on its own...

    Bortezomib Fresenius Kabi | European Medicines Agency (EMA)

    OverviewBortezomib Fresenius Kabi is a medicine used to treat multiple myeloma, a blood cancer, in the following groups of patients:previously untreated adults who...

    Locametz | European Medicines Agency (EMA)

    OverviewLocametz is a diagnostic medicine used in adults with prostate cancer to detect prostate cancer cells with a protein called prostate‑specific membrane antigen...

    Drovelis | European Medicines Agency (EMA)

    OverviewDrovelis is a combined hormonal contraceptive. It contains the active substances drospirenone and estetrol monohydrate.Expand sectionCollapse sectionHow is Drovelis used?Drovelis can only be...

    Dafiro HCT | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Actelsar HCT | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Actelsar HCT. It explains how the Agency assessed the medicine to...

    Duloxetine Viatris (previously Duloxetine Mylan)

    OverviewThis is a summary of the European public assessment report (EPAR) for Duloxetine Mylan. It explains how the Agency assessed the medicine to...